“Long COVID Vaccination” Syndrome and “Long COVID” Illness are Similar
Researchers have been working for several years on understanding why some individuals suffer a pattern of persistent health problems after being infected with SARS-CoV-21 2 or after COVID vaccination.3 4 5 Both long COVID syndrome and long post-COVID vaccination syndrome (LPVCS) are associated with similar debilitating symptoms that affect immune and brain function.6 Although U.S. […]
Ozempic Weight Loss Drug Linked to Increased Risk of Thyroid Cancers
New weight loss drug Ozempic has taken the world’s obesity epidemic by storm, but like most weight loss drugs that precede it over the past century, shedding extra pounds may not be the only outcome for consumers: Last month, the European Medicines Agency (EMA), a European Union (E.U.) agency that oversees and evaluates pharmaceutical medications, […]
Aspartame May Be Declared a Carcinogen by WHO
When doing an online search for information about aspartame, the website “Safety of Aspartame” immediately comes up as the first sponsored site offering information about the popular artificial sweetener found in Diet Coke and other “zero sugar” products. “More than 100 studies, 200 scientists, 90 countries all saying the same thing,” the website boasts, “Aspartame […]
CDC Says All Children Traveling Abroad Need Extra MMR Shot to Prevent Measles in U.S.
After 16 cases of measles were reported in the U.S. linked to international travel, the U.S. Centers for Disease Control and Prevention (CDC) issued a health alert on June 21, 2023, recommending that all eligible infants aged six months or older get an extra measles vaccine before traveling abroad this summer. Despite being licensed by […]
FDA Panel Endorses New Alzheimer’s Drug After Accelerated Approval
The newest Alzheimer’s drug is on its way for full regulatory approval after a U.S. Food and Drug Administration (FDA) advisory panel voted that the drug was beneficial in slowing cognitive decline. The drug is expected to be fully approved by July 6, 2023.1 In clinical trials the drug, known as lecanemab, demonstrated a 27 […]
Twelve Infants Die During Clinical Trials for FDA-Endorsed RSV Drug
On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to provide protection for infants from respiratory syncytial virus (RSV) disease and other lower respiratory tract infections during their first year of life.1 […]